News

U.S. panel recommends new adult vaccine against hepatitis B

U.S. panel recommends new adult vaccine against hepatitis B
Health
The vaccine, called Heplisav-B, was licensed for use in the U.S. in November and is the first new hepatitis B vaccine in 25 years.

Hepatitis B vaccines have been in childhood shots for decades. The new vaccine made by Dynavax Technologies Corp. is for adults and is given in two shots over a month. It uses an additive that boosts the body s immune response.

The hepatitis B virus can damage the liver and is spread through contact with blood or other bodily fluids. Cases have been rising, a trend linked to the heroin and opioid epidemic. Meanwhile, researchers found older vaccines falter in diabetics and older adults.

The Advisory Committee on Immunization Practices endorsed the vaccine during a meeting in Atlanta. The government usually adopts its recommendations.
Read more on CTVnews
News Topics :
Similar Articles :
Health
Another deadly case of flu in Alberta has officials once again reminding people to roll up their sleeves. So far two people have died, and Alberta Health Services say that...
Health
FILE In this Monday, March 2, 2015 photo, pharmacist Jenna Wright administers the Meningitis B vaccine to University of Oregon freshman Drew Russert during a mass vaccination clinic at...
Science
There is an optimal time of the day to get a flu shot the morning, according to a new study by researchers from the University of Birmingham and . In the...
Science
According to the latest available data, about 44 percent of adults over age 19 had a flu shot; 20 percent had a TDAP vaccine, which protects against tetanus, diphtheria and pertussis;...
Health
The number of vaccine preventable infectious diseases cases between 2005 and 2014 shot up 30 per cent, from 6, 184 to 8, 018, the Government of Canada reports. Getty Images Currently, most provinces...